STOCKS TELEGRAPH

Tag: ENDP

  • Endo International PLC (ENDP) Stock Continues Trending Down as Legal Trials Continue

    Endo International PLC (ENDP) stock prices were down 3.06% as of the market closing on July 15th, 2021, bringing the price per share down to USD$3.49 at the end of the trading day. Subsequent premarket fluctuations have seen the stock dip by 4.01%, bringing it down to USD$3.35.

    Health Canada Approval

    June 9th 2021 saw the company announce the approval of Wakix (pitolisant) by Health Canada for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy. The approval of the treatment by Health Canada will facilitate the provision of a much-needed treatment for Canadians that suffer from narcolepsy. The treatment also affords patients the option to manage their EDS or as a treatment for their cataplexy attacks. The company is continuing to offer novel treatment options to help support the unmet needs of the Canadian patient demographic.

    ENDP Partnerships

    The company intends to collaborate with the Canadian Agency for Drugs and Technologies in Health (CADTH), as well as the Institut national d’excellenceensanteen services sociaux (INESSS). This partnership will facilitate the hasty provision of Wakix to its patients. 2018 saw the company’s subsidiary, Endo Ventures Ltd., entered into an agreement with Bioproject SCR. This partnership will see the company register, commercialize and distribute pitolisant on an exclusive basis across Canada. The commercialization of pitolisant in Canada will be conduced by Paladin Labs, an operating company of ENDP.

    Ahead of the Competition

    Wakix is in a class of its own, being the first and only Health Canada approved treatment for EDS and cataplexy symptoms in adult patents with narcolepsy. The first-in-class highly selective histamine 3 receptor antagonist/inverse agonist works through an innovative and unique mechanism of action. It increases the levels of histamine and other wakefulness promoting neurotransmitters in the brain.

    Mechanics of Wakix

    The tablet is to be taken once daily, every morning upon waking up. Wakix is thus far the only treatment for cataplexy that is not a controlled drug, having been approved by Health Canada. The treatment is currently marketed across Europe and the United States, serving as a registered trademark of Bioproject Europe Ltd.

    Future Outlook for ENDP

    Armed with the massively successful scope of the commercialization of Wakix having proliferated the entirety of the North American market, ENDP is poised to capitalize on the expanded opportunities for growth. Current and potential investors are hopeful that management will be able to leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

  • 31 stocks trending in pre-market

    31 stocks trending in pre-market

    NIO Limited (NIO) stock soared 2.95% to $42.19 in the pre-market trading following the pricing of offering of 68,000,000 American depositary shares. The most recent rating by Goldman, on December 01, 2020, is a Neutral. NIO Inc.

    Veru Inc. (NASDAQ: VERU) shares are trading up 7.17% at $10.39 at the time of writing after declaring positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer, which was selected as a Spotlight Presentation at the 2020 San Antonio Breast Cancer Symposium. Company’s 52-week ranged between $2.10 to $7.86. Analysts have a consensus price target of $6.

    Occidental Petroleum Corporation (OXY) stock soared 2.45% to $19.64 in the pre-market trading. The most recent rating by MKM Partners, on December 07, 2020, is a Neutral.

    BioCardia Inc. (BCDA), a Biotechnology company, rose about 9.38% at $4.9 in pre-market trading Tuesday after reporting entry into definitive agreements with investors for the purchase and sale of 1,789,474 shares of its common stock at a purchase price of $4.75 per share in a registered direct offering priced at-the-market under Nasdaq rules.

    Genius Brands International Inc. (GNUS) gained over 15.85% at $2.12 in pre-market trading Tuesday December 15, 2020. The company recently revealed that it has secured a commitment to receive $100 million in cash on January 15, 2021 from New York-based Mudrick Capital Management as a result of a new first lien debt financing.

    Nikola Corporation (NKLA) is up more than 2.38% at $16.8 in pre-market hours Tuesday December 15, 2020. The stock had dropped over -6.87% to $16.41 in the last trading session.

    Virgin Galactic Holdings Inc. (SPCE) is up more than 2.83% at $27.22 in pre-market hours Tuesday December 15, 2020 following an update on test flight program. The stock had dropped over -17.38% to $26.47 in the last trading session.

    Before the trading started on December 15, 2020, Huntington Bancshares Incorporated (HBAN) is up 2.32% to reach $12.8 after reporting merger with TCF Financial Corporation to create top 10 U.S. regional bank. It has been trading in a 52-week range of $6.82 to $15.63.

    Plug Power Inc. (PLUG) stock soared 2.65% to $26.38 in the pre-market trading. The most recent rating by B. Riley Securities, on November 10, 2020, is a Buy.

    XPeng Inc. (NYSE: XPEV) shares are trading up 3.86% at $48.99 at the time of writing after its P7 super-long range sports sedan received car of the Year 2021 award in Xuanyuan Awards. Company’s 52-week ranged between $17.11 to $74.49. Analysts have a consensus price target of $58.

    AnPac Bio-Medical Science Co. Ltd. (ANPC), a Biotechnology company, dropped about -5.26% at $5.4 in pre-market trading Tuesday following the proclamation from the firm that it has made significant progress in detecting pre-cancer diseases.

    Yamana Gold Inc. (AUY) stock moved up 2.66 percent to $5.4 in the pre-market trading.

    Zynga Inc. (ZNGA) gained over 3.9% at $9.05 in pre-market trading Tuesday December 15, 2020 following the declaration of pricing of offering of $762 million of convertible senior notes.

    IZEA Worldwide Inc. (IZEA) is down more than -5.68% at $0.9243 in pre-market hours Tuesday December 15, 2020 after announcing that it has seen a surge of new customers in Q4 2020. The stock had jumped over 15.00% to $0.98 in the last trading session.

    Cameco Corporation (CCJ) grew over 3.16% at $13.7 in pre-market trading today.

    Before the trading started on December 15, 2020, HEXO Corp. (HEXO) is down -2.8% to reach $0.9817 after releasing its first quarter fiscal 2021 financial results. It has been trading in a 52-week range of $0.35 to $2.30.

    Nano Dimension Ltd. (NNDM) stock soared 1.8% to $6.77 in the pre-market trading. The most recent rating by Maxim Group, on October 21, 2016, is a Buy.

    Teligent Inc. (TLGT) tumbled over -3.53% at $0.78 in pre-market trading today.

    Synlogic Inc. (NASDAQ: SYBX) shares are trading down -5.51% at $2.4 at the time of writing following advancement of SYNB1891 to combination arm dosing with PD-L1 checkpoint inhibitor in the on-going phase 1 study for the treatment of solid tumors and lymphoma. Company’s 52-week ranged between $1.35 to $3.99.

    BioNTech SE (BNTX) stock soared 5.48% to $114.2 in the pre-market trading. The most recent rating by BofA Securities, on December 01, 2020, is a Neutral. Pfizer Inc. (PFE) and BioNTech SE (BNTX) recently declared additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial with BNT162b2 conducted in Germany

    Torchlight Energy Resources Inc. (TRCH) tumbled over -12.14% at $0.543 in pre-market trading today.

    Seelos Therapeutics Inc. (SEEL) stock moved up 5.47 percent to $1.35 in the pre-market trading after revealing the sale of a $12.0 million senior secured convertible note and shares of Seelos common stock to investors.

    Bed Bath & Beyond Inc. (BBBY) gained over 4.35% at $19.69 in pre-market trading Tuesday December 15, 2020 following the declaration of definitive agreement to sell its remaining non-core banner Cost Plus World Market (CPWM) to Kingswood Capital Management, a Los Angeles-based private equity firm.

    Before the trading started on December 15, 2020, Aerpio Pharmaceuticals Inc. (ARPO) is down -3.33% to reach $1.16. It has been trading in a 52-week range of $0.42 to $2.31.

    Before the trading started on December 15, 2020, Energy Fuels Inc. (UUUU) is up 2.94% to reach $3.15 after reporting that it has entered into a three-year supply agreement with The Chemours Company (CC) to acquire a minimum of 2,500 tons per year of natural monazite sands. It has been trading in a 52-week range of $0.78 to $3.10.

    Uranium Energy Corp. (UEC) grew over 5.62% at $1.69 in pre-market trading today after filing fiscal 2021 Q1 quarterly report.

    MicroVision Inc. (MVIS), a Scientific & Technical Instruments company, rose about 5.43% at $3.3 in pre-market trading Tuesday.

    NovaBay Pharmaceuticals Inc. (NBY) is down more than -2.28% at $0.68 in pre-market hours Tuesday December 15, 2020 after reporting that its proprietary hypochlorous acid solution has received U.S. Environmental Protection Agency (EPA) approval for a kill claim against SARS-CoV-2, the virus that causes COVID-19. The stock had jumped over 0.86% to $0.70 in the last trading session.

    vTv Therapeutics Inc. (VTVT), a Biotechnology company, dropped about -10.44% at $2.66 in pre-market trading Tuesday after declaring a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.

    Socket Mobile Inc. (NASDAQ: SCKT) shares are trading down -15.38% at $2.42 at the time of writing. Company’s 52-week ranged between $0.76 to $4.50.

    ArcelorMittal (MT) grew over 4.3% at $22.08 in pre-market trading today after announcing investment agreement with Invitalia, an Italian state-owned company.

  • Top 15 Healthcare Stocks You Should Add To Your Bucket

    The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for more generic drugs. This industry is an opportunity-rich industry. Efficient and inexpensive drugs are often needed. The drug manufacturing industry has seen a huge transformation over the last two decades.

    This industry-main challenge is to provide the drug at lower prices than branded drugs. Drug manufacturers and Specialty Generic Industry will face more pressure in the coming years to lower the prices of drugs.  The industry is expected to grow significantly over the next decade. Check out the leading companies in drug manufacturers- specialty generic industry to see how these are addressing the needs of their customers:

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) shares were trading down -6.32% at $0.17 at the time of writing on Wednesday. Sundial Growers Inc. (NASDAQ: SNDL) share price went from a low point around $0.17 to briefly over $4.12 in the past 52 weeks, though shares have since pulled back to $0.17. SNDL market cap has remained high, hitting $32.59M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Sundial Growers Inc. (SNDL) has revealed earlier that it has expanded the Palmetto brand presence across Canada. If we look at the recent analyst rating SNDL, CIBC upgraded coverage on SNDL shares with a Neutral rating.

    Teligent Inc. (NASDAQ: TLGT)

    Teligent Inc. (NASDAQ: TLGT) last closed at $1.04, in a 52-week range of $0.65 to $8.00. The Schall Law Firm has earlier revealed that it is investigating claims on behalf of investors in Teligent, Inc. for potential breaches of fiduciary duty on the part of its directors and management. Teligent Inc.’s market cap has remained high, hitting $5.68 Million at the time of writing.

    Zomedica Corp. (AMEX: ZOM)

    Zomedica Corp. (AMEX: ZOM) stock drop by -3.82% to $0.08. Zomedica Corp. (ZOM) revealed that it has changed its legal name to Zomedica Corp. The Company’s stock trading symbol will remain as ZOM on the NYSE American and the shares will start trading under the new name effective on October 5, 2020.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) shares headed rising, higher as much as 6.36%. The most recent rating by Jefferies, on September 21, 2020, is at a Hold. Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of Aurora Cannabis Inc. (ACB) shareholders.

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) rose 2.96% after gaining more than $0.19 on Wednesday. Tilray Inc. (TLRY) earlier revealed that its wholly-owned subsidiary, High Park Holdings Ltd. has introduced the newest addition to its cannabis-infused edible product line: Chowie Wowie Gummies, which are now available in select provinces across Canada.

    Neos Therapeutics Inc. (NASDAQ: NEOS)

    Neos Therapeutics Inc. (NASDAQ: NEOS) last closed at $0.86, in a 52-week range of $0.45 to $1.98. Neos Therapeutics Inc. (NEOS) has reported that its sales in quarter two reached $13.13 million. However, earnings dropped by 51.17%, resulting in a loss of $2.88 million. In Q1, Neos Therapeutics brought in $14.49 million in sales but lost $5.89 million in earnings.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares headed rising, higher as much as 3.72%. The most recent rating by Barclays, on August 06, 2020, is at an Equal-weight. Pomerantz LLP revealed that a class action lawsuit has been lodged against Teva Pharmaceuticals Industries Limited and certain of its officers.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) shares headed falling, lower as much as -2.56%. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Overweight. Elanco Animal Health Incorporated (ELAN) has revealed that it has got a notification of an unsolicited ‘mini-tender”‘ offer by TRC Capital Investment Corporation to buy up to 4,000,000 shares of Elanco common stock, representing approximately 1.00% of the outstanding shares of Elanco common stock.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -0.91% after losing more than -$0.01 on Wednesday. HEXO Corp. (HEXO) has earlier disclosed that it has appointed Trent MacDonald to its executive leadership team in the acting role of Chief Financial Officer, effective October 10, 2020. Its market cap has remained high, hitting $365.78 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (BHC) last closed at $17.57, in a 52-week range of $11.15 to $31.97. Analysts have a consensus price target of $26.76. Bausch Health Companies Inc. (BHC) and Lomb, its leading global eye health business, along with BHVI, revealed previously that an affiliate of Bausch Health has bought an exclusive license for a myopia control contact lens design developed by BHVI.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) stock drop by -5.69% to $5.47. The most recent rating by Goldman, on July 27, 2020, is at a Sell. Endo International plc (ENDP) revealed that it has decided to buy all of the outstanding shares of BioSpecifics Technologies Corp. for $88.50 in cash per share or an estimated enterprise value of approximately $540 million at the expected time of deal closure.

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) stock soar by 9.65% to $0.31. China SXT Pharmaceuticals Inc. (SXTC) share has fluctuated between the 52-weeks low of $0.22 and 52-weeks high of $1.56 during the trading session of Wednesday. It has moved up 40.64% from its 52-weeks low and moved down -79.97% from its 52-weeks high.

    Canopy Growth Corporation (NYSE: CGC)

    Canopy Growth Corporation (NYSE: CGC) rose 3.23% after gaining more than $0.61 on Wednesday. Canopy Growth Corporation (CGC) share price went from a low point around $9.00 to briefly over $25.97 in the past 52 weeks, though shares have since pulled back to $19.49. CGC market cap has remained high, hitting $7.24 billion at the time of writing.

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) last closed at $4.68, in a 52-week range of $1.95 to $6.44. Aphria Inc. (APHA) has moved up 140.00% from its 52-weeks low and moved down -27.33% from its 52-weeks high. Its market cap has remained high, hitting $1.25 billion at the time of writing.

    China Pharma Holdings Inc. (CPHI)

    China Pharma Holdings Inc. (CPHI) stock soar by 6.86% to $0.50. The most recent rating by Rodman & Renshaw, on January 08, 2010, is at an Mkt outperform. China Pharma Holdings Inc. (CPHI) has moved up 134.13% from its 52-weeks low and moved down -64.53% from its 52-weeks high. Its market cap has remained high, hitting $22.72 million at the time of writing.

  • Here’s 15 Trending Stocks In Healthcare Industry To Watch

    Here’s 15 Trending Stocks In Healthcare Industry To Watch

    The global drug manufacturers specialty & generic industry continues to grow with the increase in the demand for medication. Efficient and inexpensive drugs are the main priority of customers. Drug manufacturing is more progressive with the advent of new technologies than other areas of the pharmaceutical industry. Companies are busy in acquisitions, collaborations to increase the specialty generic capacities.

    The development of cost-effective drugs and specialty generics is a complex process.  The drug generic market has seen a huge transformation over the last few decades. Its main competitive edge is the lower prices than branded drugs. The generic industry has experienced various changes as the coronavirus pandemic takes over the world. The purchase behaviors of customers also change in 2020.

    There are various companies which are fulfilling the needs of customers in the generic industry. Here are the top 15 best players in Drug manufacturers Specialty and Generic Industry:

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM)

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM) shares were trading down -2.18% at $0.11 at the time of writing on Friday. Zomedica Pharmaceuticals Corp. (AMEX: ZOM) share price went from a low point around $0.10 to briefly over $0.50 in past 52 weeks, though shares have since pulled back to $0.11.

    Zomedica Pharmaceuticals Corp. (ZOM) is scheduled to present at H.C. Wainwright Virtual Global Investment Conference on September 14, 2020. Zomedica has earlier partnered with Qorvo Biotechnologies to develop three new assays Cobalamin, Canine Pancreatic Lipase, and Folate to target the diagnosis of canine gastrointestinal issues. ZOM market cap has remained high, hitting $62.09M at the time of writing.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) last closed at $8.79, in a 52-week range of $6.25 to $13.76. Analysts have a consensus price target of $12.19. Teva Pharmaceutical Industries Limited (TEVA) affiliate Teva Neuroscience, Inc. earlier disclosed that new study data on AUSTEDO will be presented at the International Parkinson and Movement Disorder Society annual congress (MDS Virtual Congress 2020) and during the Psych Congress 2020 Virtual Experience. Teva market cap has remained high, hitting $9.79 billion at the time of writing.

    Mylan N.V. (NASDAQ: MYL)

    Mylan N.V. (NASDAQ:; MYL) stock soar by 1.79% to $15.33. The most recent rating by SVB Leerink, on January 27, 2020, is at an Mkt perform. Mylan N.V. (MYL) has earlier bought Aspen Pharmacare Holdings Limited’s thrombosis business in Europe for €641.9 million. Mylan will pay the upfront payment of €263.2 million to Aspen. After generating cash from existing operations it will pay the €378.7 million on June 25, 2021. It has a market capitalization of $7.79 billion at the time of writing.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) last closed at $6.98, in a 52-week range of $5.30 to $78.00. Aurora Cannabis Inc. (ACB) has earlier appointed Miguel Martin its chief executive officer and also disclosed that it would book up to C$1.8 billion ($1.37 billion) in restructuring charges. It has a total market capitalization of $785.74 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (NYSE: BHC) fall -1.60% after losing more than -$0.25 on Friday. Bausch Health Companies Inc. (BHC) has earlier shared its Inaugural Activity Report which showed the efforts of the Foundation from late 2017 through June 30, 2020.  Bausch Health Companies Inc. striving to improve the lives of patients globally. It has a total market cap of $5.58 billion at the time of writing.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) last closed at $2.80, in a 52-week range of $2.08 to $7.10. Endo International plc (ENDP) has earlier participated in the Citi 15th Annual BioPharma Virtual Conference being held on September 8-10, 2020. Endo International plc market cap has remained high, hitting $629.69 million at the time of writing.

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) Shares headed falling, lower as much as -0.50%. The most recent rating by CIBC, on August 17, 2020, is at a Neutral. Sundial Growers Inc. (NASDAQ: SNDL) is scheduled to participate in
    Alliance Global Partners’ Consumer Cannabis Conference. Zachary George, Chief Executive Officer of Sundial, will take part in one-on-one sessions on September 29, 2020.

    Cronos Group Inc. (NASDAQ: CRON)

    Cronos Group Inc. (NASDAQ: CRON) fall -1.51% after losing more than -$0.08 on Friday. Cronos Group Inc. (NASDAQ: CRON) announced that its Board of Directors has named Kurt Schmidt President and Chief Executive Officer of the Company, effective September 9, 2020.  CRON also disclosed that Mike Gorenstein has been chosen as the Executive Chairman. Mike has worked as Chairman, President, and Chief Executive Officer of Cronos Group since 2016.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) last closed at $27.08, in a 52-week range of $15.17 to $32.66. Analysts have a consensus price target of $26.43. Elanco Animal Health Incorporated (NYSE: ELAN) is scheduled to participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Tuesday, September 15, 2020.  Elanco Animal Health Incorporated market cap remained high, hitting $10.86 billion at the time of writing.

    Agile Therapeutics Inc. (NASDAQ: AGRX)

    Agile Therapeutics Inc. (NASDAQ: AGRX) stock soar by 2.54% to $3.63. The most recent rating by Janney, on April 12, 2019, is at a Buy. Agile Therapeutics Inc. (AGRX) is scheduled to host a virtual investor/Analyst day on Monday, September 21, 2020. It has also introduced I’m So Done, an education and empowerment platform that encourages women to think about their current contraceptive method and decision-making journey.

    Mallinckrodt plc (NYSE: MNK)

    Mallinckrodt plc (NYSE: MNK) Shares headed falling, lower as much as -7.69%. The most recent rating by JP Morgan, on May 19, 2020, is at an Underweight. Mallinckrodt plc (MNK) share price went from a low point around $1.00 to briefly over $6.42 in the past 52 weeks, though shares have since pulled back to $1.20. Mallinckrodt plc market cap has remained high, hitting $110.00 million at the time of writing.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -2.82% after losing more than -$0.02 on Friday. HEXO Corp. (HEXO) share price went from a low point around $0.35 to briefly over $4.62 in the past 52 weeks, though shares have since pulled back to $0.62. HEXO Corp. market cap has remained high, hitting $331.70 million at the time of writing

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) stock drop by -5.68% to $5.31. The most recent rating by The Benchmark Company, on May 12, 2020, is at a Buy. Tilray Inc. (TLRY) stock fluctuated between the 52-weeks low range of $2.43 and a high range of $32.77. It has moved up 118.52% from its 52-weeks low and moved down -83.80% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.80. Its market capitalization is $716.00 million.

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) shares headed falling, lower as much as -0.12%. The most recent rating by Cowen, on August 03, 2020, is at an Outperform. Momenta Pharmaceuticals Inc. (MNTA)  share price went from a low point around $12.21 to briefly over $52.33 in the past 52 weeks, though shares have since pulled back to $52.08. Momenta Pharmaceuticals Inc. market cap has remained high, hitting $6.20 Billion at the time of writing

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) stock drop by -2.81% to $4.50. The most recent rating by CIBC, on August 17, 2020, is at a Sector outperform. Aphria Inc. (APHA) stock fluctuated between the 52-weeks low range of $1.95 and a high range of $7.04. It has moved up 130.77% from its 52-weeks low and moved down -36.08% from its 52-weeks high. Its market capitalization is $1.20 Billion.